Pathbreaking Advances in Nanomedicine in Ovarcoming Ovarian Cancer

In this episode of Connect Ovar Coffee, Dr. Daniel Heller, Head of Cancer Nanomedicine Lab at Memorial Sloan Kettering Cancer Center joins us to Talk About The Promise of Pathbreaking Advances in Ovarian Cancer With Nanomedicine.
Listen. Learn. Share. Let's #ConnectOvarCoffee!
Ovarcome